What is MLEC stock price today?

MLEC (Moolec Science SA Ordinary Shares) stock is trading at $7.42 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MLEC stock going up or down today?

MLEC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MLEC stock now?

The decision to buy MLEC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MLEC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MLEC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MLEC stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MLEC is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MLEC's P/E ratio?

P/E ratio data for MLEC will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MLEC's market cap?

MLEC (Moolec Science SA Ordinary Shares) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is MLEC's price to book ratio?

MLEC trades at a price-to-book (P/B) ratio of 0.55, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MLEC pay dividends?

MLEC does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MLEC's dividend yield?

MLEC does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MLEC stock a good long-term investment?

MLEC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MLEC's revenue growth rate?

MLEC has shown revenue growth of 9.5% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for MLEC are available on our dashboard with complete income statement analysis.

What are the risks of investing in MLEC?

Key risks for MLEC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MLEC compare to its competitors?

Compare MLEC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MLEC's performance and positioning.

What is MLEC's stock price target for 2026?

Our AI model provides price targets for MLEC based on fundamental analysis: Bull case $9.65 (+30%), Base case $8.54 (+15%), Bear case $6.68 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MLEC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MLEC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MLEC's next earnings report?

MLEC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MLEC - Moolec Science SA Ordinary Shares

NYSE * Healthcare * Biotechnology

$7.42

$-0.61 (-7.65%)

About Moolec Science SA Ordinary Shares

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Price Chart

Loading chart...

MLEC Key Statistics

Market Cap

$5.88M

P/B Ratio

0.55

EPS

$-199.02

Revenue Growth

+9.5%

How MLEC Compares to Peers

MLEC has the fastest revenue growth among competitors

MLEC is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MLEC(This stock)	$5.88M	N/A	9%	0.0%	-
AMGNAmgen Inc	$186.52B	24.0	0%	0.2%	vs AMGN
GILDGilead Sciences	$160.39B	17.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.12B	26.2	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$66.84B	15.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$29.00B	21.1	0%	0.1%	vs BIIB

Moolec Science SA Ordinary Shares Company Information

Headquarters: 89 Nexus Way, Grand Cayman, Cayman Islands, KY1-9009, undefined
Website: www.moolecscience.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: June 5, 2026 at 1:41 PM EDT

Ready to invest in MLEC?

Commission-free trading available. Affiliate links.

Upcoming Events for MLEC

Dashboard

Enter a ticker to analyze